
- August 2018 Pain Awareness
- Volume 84
- Issue 8
Generic Product News (August 2018)
ATAZANAVIR CAPSULES
MARKETED BY: Aurobindo Pharma
COMPARE TO: Reyataz
INDICATION: Aurobindo has received FDA approval to launch atazanavir capsules, an AB-rated generic equivalent to Reyataz. Atazanavir can be used to treat
DOSAGE FORM: Sublingual film
FOR MORE INFORMATION: aurobindousa.com
BUPRENORPHINE AND NALOXONE SUBLINGUAL FILMS
MARKETED BY: Mylan Technologies, Inc, and Dr. Reddy’s Laboratories SA
COMPARE TO: Suboxone
INDICATION: The FDA recently approved the first generic versions of sublingual films indicated to treat opioid dependency, with hopes of reducing the cost and increasing access to treatment for patients. Buprenorphine and Naloxone Sublingual films are AB-graded generic equivalents to Suboxone.
DOSAGE FORM: Sublingual film
FOR MORE INFORMATION: mylan.com and drreddys.com
HYDROXYPROGESTERONE CAPROATE INJECTION, USP
MARKETED BY: American Regent
COMPARE TO: Makena
INDICATION: The FDA has approved Hydroxyprogesterone Caproate Injection, USP, to prevent preterm birth in
DOSAGE FORM: Injection
FOR MORE INFORMATION: americanregent.com
STERI-DROPPER 10 PACK
MARKETED BY: Medi-Dose Inc
INDICATION: Medi-Dose has released new packaging for its Steri-Dropper, to make
FOR MORE INFORMATION: Medidose.com
Articles in this issue
about 7 years ago
A Portable Nebulizer Option for Patients With COPDabout 7 years ago
Women in Pharmacy Leadership: It Takes Gritabout 7 years ago
Do Common Analgesics Beat Opioids for Dental Pain Relief?about 7 years ago
Rx Product News (August 2018)about 7 years ago
PTCB Sees Success in Advanced Technician Certification Programabout 7 years ago
Pet Peeves (August 2018)about 7 years ago
Let's Get Down to Business: The Value of Pharmacy Immunizationabout 7 years ago
What Is the Ultimate Cost of Rx Abuse?Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.













































































































































































































